10002-29-6 Usage
General Description
(Pyridin-2-ylsulfanyl)-acetic acid, also known as 2-(pyridin-2-ylsulfanyl)acetic acid, is a chemical compound with the molecular formula C7H7NO2S. (PYRIDIN-2-YLSULFANYL)-ACETIC ACID belongs to the class of organic compounds known as pyridines and derivatives, which are compounds containing a pyridine ring, a six-membered aromatic heterocycle in which one carbon atom is replaced by a nitrogen atom. As a derivative, it has a sulfanyl group attached at the carbon-2 position and an acetic acid group. This chemical is relatively less researched and may have potential applications in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 10002-29-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,0,0 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 10002-29:
(7*1)+(6*0)+(5*0)+(4*0)+(3*2)+(2*2)+(1*9)=26
26 % 10 = 6
So 10002-29-6 is a valid CAS Registry Number.
10002-29-6Relevant articles and documents
Screening of ligands for the Ullmann synthesis of electron-rich diaryl ethers
Otto, Nicola,Opatz, Till
supporting information; experimental part, p. 1105 - 1111 (2012/09/07)
In the search for new ligands for the Ullmann diaryl ether synthesis, permitting the coupling of electron-rich aryl bromides at relatively low temperatures, 56 structurally diverse multidentate ligands were screened in a model system that uses copper iodide in acetonitrile with potassium phosphate as the base. The ligands differed largely in their performance, but no privileged structural class could be identified.
CHEMOKINE RECEPTOR BINDING COMPOUNDS
-
Page/Page column 72, (2008/06/13)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. Thesd compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
